Filter
368
Filtered Results: 368
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
43
New Publications
125
Language
Document type
No document type
204
Guidelines
60
Studies & Reports
47
Strategic & Response Plan
21
Manuals
20
Fact sheets
7
Training Material
5
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
India
15
Ghana
14
Uganda
14
Global
13
Western and Central Europe
13
Eastern Europe
11
Nepal
10
Rwanda
10
South Africa
10
Namibia
9
Sierra Leone
7
Malawi
7
Ethiopia
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Africa
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
187
Clinical Guidelines
41
Public Health
9
Women & Child Health
6
Key Resources
5
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
TB
45
Pharmacy
40
AMR
31
COVID-19
23
HIV
17
NTDs
15
Malaria
13
NCDs
4
Ebola & Marburg
3
Specific Hazards
2
Refugee
2
Caregiver
2
Planetary Health
2
Rapid Response
1
Cholera
1
Polio
1
Global Health Education
1
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
HIV i-Base
July 2018
Master of Science in Pharmaceutical Management Dissertation
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
Towards ending tuberculosis and multidrug-resistant tuberculosis.
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...
